Greenstreet is the CEO of Alnylam Pharmaceuticals. Over the past two decades, scientists have developed a revolutionary new class of medicines with the power to halt or even reverse disease. These ...
The Inflation Reduction Act (IRA) of 2022 changed the financing and risk-bearing obligations of Medicare Part D prescription drug plans in 2025. We used the Medicare 2021–25 public use files to ...
The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results